Smartleaf Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$651K Hold
13,470
0.02% 503
2026
Q1
$475K Sell
13,470
-3,665
-21% -$174K 0.02% 545
2025
Q4
$878K Sell
17,135
-2,484
-13% -$127K 0.03% 401
2025
Q3
$1.09M Buy
19,619
+4,641
+31% +$272K 0.07% 305
2025
Q2
$1.03M Sell
14,978
-2,124
-12% -$144K 0.09% 247
2025
Q1
$1.19M Sell
17,102
-686
-4% -$56.7K 0.11% 200
2024
Q4
$1.52M Buy
17,788
+8,351
+88% +$903K 0.16% 147
2024
Q3
$1.14M Buy
9,437
+4,168
+79% +$556K 0.14% 171
2024
Q2
$761K Buy
5,269
+1,006
+24% +$133K 0.12% 187
2024
Q1
$546K Buy
4,263
+110
+3% +$13.1K 0.11% 208
2023
Q4
$430K Buy
+4,153
New +$411K 0.12% 182

Other funds holding NVO

Smartleaf Asset Management's NVO Position: Q2 2026 in Review

Smartleaf Asset Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 13,470 shares worth $651K. The position accounts for 0.02% of the portfolio, ranked #503.

Smartleaf Asset Management first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.52M in Q4 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Smartleaf Asset Management held 13,470 shares of Novo Nordisk worth $651K as of Q2 2026.
  • Smartleaf Asset Management left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.02% of Smartleaf Asset Management's portfolio in Q2 2026, its #503 holding.
  • Smartleaf Asset Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's Novo Nordisk position peaked at $1.52M in Q4 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.